Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
3.110
+0.810 (35.22%)
Oct 3, 2025, 3:35 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2018FY 20172016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '18 Dec '17 2016
Innovative Cell-based Technologies
1.37M
Log In
Log In
Log In
Log In
Upgrade
Innovative Cell-based Technologies Growth
124.34%
Log In
Log In
Log In
Log In
Upgrade
License Fees
-
Log In
Log In
Log In
Log In
Upgrade
Product
-
Log In
Log In
Log In
Log In
Upgrade
Royalties
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2018FY 20172016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '18 Dec '17 2016
United States
1.37M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
124.34%
Log In
Log In
Log In
Log In
Upgrade
International
-
Log In
Log In
Log In
Log In
Upgrade
International Growth
-
Log In
Log In
Log In
Log In
Upgrade